 |
| San Francisco, January, 2007 |
Successful Restructuring of Creditor Liabilities and Termination of a Prohibitive Real Estate Executory Contract |
Steven R. Gerbsman, Principal of Gerbsman Partners announced today the success
in maximizing stakeholder value for a life science company that was
engaged in the development of products for peripheral artery disease.
Due to market conditions, the public company made the strategic
decision to maximize the value of the business and Intellectual
Property, conduct an orderly wind down of remaining operations and find
an acquirer for the public vehicle. Gerbsman Partners provided
leadership to the company with:
- Crisis
Management and creditor work out experience in developing the strategic
action plans for maximizing value of the business;
- Proven domain creditor restructuring and real estate lease termination expertise;
- The ability to "Manage the Process" among, Creditors, the Real Estate landlord and the company; and
- The proven ability to "Drive" toward successful closure for all parties at interest.
Gerbsman
Partners focuses on maximizing enterprise value for stakeholders and
shareholders in under-performing, under-capitalized and under-valued
companies and their Intellectual Property. In the past 60 months,
Gerbsman Partners has been involved in maximizing value for 26
Technology and Life Science companies and their Intellectual Property
and has restructured/terminated over $690 million of real estate
executory contracts and equipment lease/sub-debt obligations. Since
inception, Gerbsman Partners has been involved in over $1.9 billion of
financings, restructurings and M&A transactions.
Gerbsman Partners has offices and strategic alliances in North America, Europe and Israel. |
|
|
|
|
|
|
